Global Electrostatic Live Cell Encapsulation Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Electrostatic Live Cell Encapsulation Market Insights, Forecast to 2034
Live cell encapsulation has long been proposed as a solution to many therapeutic problems in modern medicine. Cell encapsulation technology is used to immobilise cells within biocompatible and semipermeable membranes. Encapsulation of cells, rather than therapeutic products, is used to allow the delivery of molecules of interest for a longer time period because cells release these molecules of interest continuously. Furthermore, cells can be engineered to express the desired protein in vivo without modifying the host's genome. Cell encapsulation has a significant advantage over protein encapsulation because it allows for the sustained and controlled delivery of therapeutic molecules at a constant rate, resulting in higher physiological concentrations.
Market Analysis and InsightsGlobal Electrostatic Live Cell Encapsulation Market
Global Electrostatic Live Cell Encapsulation market is expected to reach to US$ 309 million in 2023, with a positive growth of %, compared with US$ 297 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Electrostatic Live Cell Encapsulation industry is evaluated to reach US$ 395.5 million in 2033. The CAGR will be 4.2% during 2023 to 2033.
Globally, Electrostatic Live Cell Encapsulation key companies include ViaCyte, MIKROCAPS, Balchem Inc, Sernova Corp, Blacktrace Holdings Limited, Merck KGaA, BÜCHI Labortechnik AG, PharmaCyte Biotech and Living Cell Technologies Limited, etc. ViaCyte, MIKROCAPS, Balchem Inc are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Electrostatic Live Cell Encapsulation were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Electrostatic Live Cell Encapsulation market and estimated to attract more attentions from industry insiders and investors.
Electrostatic Live Cell Encapsulation can be divided into Alginate, HEMA-MMA, Chitosan and Siliceous Encapsulates, etc. Alginate is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Electrostatic Live Cell Encapsulation is widely used in various fields, such as Pharmacy, Regenerative Medicine, Cell Transplantation and Other, etc. Pharmacy provides greatest supports to the Electrostatic Live Cell Encapsulation industry development. In 2022, global % revenue of Electrostatic Live Cell Encapsulation went into Pharmacy filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Electrostatic Live Cell Encapsulation market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Electrostatic Live Cell Encapsulation market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
ViaCyte
MIKROCAPS
Balchem Inc
Sernova Corp
Blacktrace Holdings Limited
Merck KGaA
BÜCHI Labortechnik AG
PharmaCyte Biotech
Living Cell Technologies Limited
Sigilon Therapeutics, Inc
Encapsys, LLC
Neurotech LLC
LycoRed Ltd
Beta-O2 Technologies Ltd
DuPont
Austrianova
Segment by Type
Alginate
HEMA-MMA
Chitosan
Siliceous Encapsulates
Cellulose Sulfate
PAN-PVC
Other
Pharmacy
Regenerative Medicine
Cell Transplantation
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Electrostatic Live Cell Encapsulation introduction, etc. Electrostatic Live Cell Encapsulation Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Electrostatic Live Cell Encapsulation
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Electrostatic Live Cell Encapsulation Market
Global Electrostatic Live Cell Encapsulation market is expected to reach to US$ 309 million in 2023, with a positive growth of %, compared with US$ 297 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Electrostatic Live Cell Encapsulation industry is evaluated to reach US$ 395.5 million in 2033. The CAGR will be 4.2% during 2023 to 2033.
Globally, Electrostatic Live Cell Encapsulation key companies include ViaCyte, MIKROCAPS, Balchem Inc, Sernova Corp, Blacktrace Holdings Limited, Merck KGaA, BÜCHI Labortechnik AG, PharmaCyte Biotech and Living Cell Technologies Limited, etc. ViaCyte, MIKROCAPS, Balchem Inc are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Electrostatic Live Cell Encapsulation were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Electrostatic Live Cell Encapsulation market and estimated to attract more attentions from industry insiders and investors.
Electrostatic Live Cell Encapsulation can be divided into Alginate, HEMA-MMA, Chitosan and Siliceous Encapsulates, etc. Alginate is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Electrostatic Live Cell Encapsulation is widely used in various fields, such as Pharmacy, Regenerative Medicine, Cell Transplantation and Other, etc. Pharmacy provides greatest supports to the Electrostatic Live Cell Encapsulation industry development. In 2022, global % revenue of Electrostatic Live Cell Encapsulation went into Pharmacy filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Electrostatic Live Cell Encapsulation market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Electrostatic Live Cell Encapsulation market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
ViaCyte
MIKROCAPS
Balchem Inc
Sernova Corp
Blacktrace Holdings Limited
Merck KGaA
BÜCHI Labortechnik AG
PharmaCyte Biotech
Living Cell Technologies Limited
Sigilon Therapeutics, Inc
Encapsys, LLC
Neurotech LLC
LycoRed Ltd
Beta-O2 Technologies Ltd
DuPont
Austrianova
Segment by Type
Alginate
HEMA-MMA
Chitosan
Siliceous Encapsulates
Cellulose Sulfate
PAN-PVC
Other
Segment by Application
Pharmacy
Regenerative Medicine
Cell Transplantation
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Electrostatic Live Cell Encapsulation introduction, etc. Electrostatic Live Cell Encapsulation Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Electrostatic Live Cell Encapsulation
Chapter 13Methodology and Data Sources adopted by MRAResearch
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices